All Pharma News
Moderna shares fall after judge sides with Arbutus in patent fight

Moderna shares fall after judge sides with Arbutus in patent fight
REUTERS
04 Apr 2024
Share Share
Roivant`s anti-inflammatory drug shows promise in mid-stage study

Roivant`s anti-inflammatory drug shows promise in mid-stage study
Bhanvi Satija REUTERS
03 Apr 2024
Share Share
Roivant launches $1.5 billion share buyback program

Roivant launches $1.5 billion share buyback program
PRESS RELEASE
02 Apr 2024
Share Share
Roivant`s Hemavant bet winds down after cutting ex-Eisai drug

Roivant`s Hemavant bet winds down after cutting ex-Eisai drug
FIERCE BIOTECH
14 Feb 2024
Share Share
Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023

Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023
GLOBENEWSWIRE
13 Feb 2024
Share Share
Roivant to Report Financial Results for the Q3 Ended December 31, 2023

Roivant to Report Financial Results for the Q3 Ended December 31, 2023
GLOBENEWSWIRE
30 Jan 2024
Share Share
Vivek Ramaswamy gives up presidential bid, no plans to return to Roivant

Vivek Ramaswamy gives up presidential bid, no plans to return to Roivant
ENDPTS
16 Jan 2024
Share Share
JPM24: Roivant CEO has ‘pangs of regret’ for letting Telavant go

JPM24: Roivant CEO has ‘pangs of regret’ for letting Telavant go
Annalee Armstrong FIERCE BIOTECH
12 Jan 2024
Share Share
JPM24, Day 3: Gene editors talk BD; Roivant has cash to spend

JPM24, Day 3: Gene editors talk BD; Roivant has cash to spend
Ben Adams FIERCE BIOTECH
10 Jan 2024
Share Share
Roivant Reports Positive Phase 2 Results for Batoclimab in Graves™ Disease

Roivant Reports Positive Phase 2 Results for Batoclimab in Graves™ Disease
GLOBENEWSWIRE
20 Dec 2023
Share Share